Centessa Pharmaceuticals (CNTA)
NASDAQ: CNTA
· Real-Time Price · USD
18.07
0.43 (2.44%)
At close: Aug 15, 2025, 12:49 PM
2.44% (1D)
| Bid | 18.03 |
| Market Cap | 2.42B |
| Revenue (ttm) | 15M |
| Net Income (ttm) | -223.85M |
| EPS (ttm) | -1.85 |
| PE Ratio (ttm) | -9.77 |
| Forward PE | -11.39 |
| Analyst | Buy |
| Ask | 18.08 |
| Volume | 580,310 |
| Avg. Volume (20D) | 1,092,862 |
| Open | 17.23 |
| Previous Close | 17.64 |
| Day's Range | 17.23 - 18.08 |
| 52-Week Range | 9.60 - 19.09 |
| Beta | 1.49 |
About CNTA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CNTA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CNTA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Centessa Pharmaceuticals is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-8.03%
Centessa Pharmaceuticals shares are trading lower ...
Unlock content with
Pro Subscription
11 months ago
+12.52%
Centessa Pharmaceuticals shares are trading higher. The company announced it priced a $225 million public offering of 15,254,237 American Depositary Shares at $14.75 per ADS
